Nivolumab and Yttrium-90 in Treating Patients With Liver Cancer Undergoing Surgical Resection

NCT03812562 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Lack of funding

Conditions

Hepatocellular Carcinoma

Interventions

BIOLOGICAL: Nivolumab
RADIATION: Yttrium Y 90 Glass Microspheres

Sponsor

Northwestern University

Collaborators

[object Object]
[object Object]